RT Journal Article
SR Electronic
T1 Clinical significance of IgM and IgG test for diagnosis of highly suspected COVID-19 infection
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.28.20029025
DO 10.1101/2020.02.28.20029025
A1 Jia, Xingwang
A1 Zhang, Pengjun
A1 Tian, Yaping
A1 Wang, Junli
A1 Zeng, Huadong
A1 Wang, Jun
A1 Liu, Jiao
A1 Chen, Zeyan
A1 Zhang, Lijun
A1 He, Haihong
A1 He, Kunlun
A1 Liu, Yajie
YR 2020
UL http://medrxiv.org/content/early/2020/03/12/2020.02.28.20029025.abstract
AB Quick, simple and accurate diagnosis of suspected COVID-19 is very important for the screening and therapy of patients. Although several methods were performed in clinical practice, however, the IgM and IgG diagnostic value evaluation was little performed. 57 suspected COVID-19 infection patients were enrolled in our study. 24 patients with positive and 33 patients with negative nucleic acid test. The positive rate of COVID-19 nucleic acid was 42.10%. The positive detection rate of combination of IgM and IgG for patients with COVID-19 negative and positive nucleic acid test was 72.73% and 87.50%. The results were significantly higher than the nucleic acid or IgM, IgG single detection. hsCRP in the COVID-19 nucleic acid negative group showed significantly higher than the positive groups (P=0.0298). AST in the COVID-19 IgM negative group showed significantly lower than the positive groups (P=0.0365). We provided a quick, simple, accurate aided detection method for the suspected patients and on-site screening in close contact with the population.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study was approved by the Ethics Committee of Shenzhen Hospital, Southern Medical University (NYSZYYEC20200009)Funding StatementNo Funding supported this studyAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used to support the findings of this study are available from the corresponding author upon request.